Lluís Ballell

4.0k total citations
64 papers, 2.1k citations indexed

About

Lluís Ballell is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Lluís Ballell has authored 64 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 36 papers in Molecular Biology and 16 papers in Epidemiology. Recurrent topics in Lluís Ballell's work include Tuberculosis Research and Epidemiology (35 papers), Cancer therapeutics and mechanisms (15 papers) and Biochemical and Molecular Research (13 papers). Lluís Ballell is often cited by papers focused on Tuberculosis Research and Epidemiology (35 papers), Cancer therapeutics and mechanisms (15 papers) and Biochemical and Molecular Research (13 papers). Lluís Ballell collaborates with scholars based in Spain, United Kingdom and United States. Lluís Ballell's co-authors include Robert J. Young, Robert A. Field, David Barros, Ken Duncan, Gurdyal S. Besra, Roland J. Pieters, Rob M. J. Liskamp, Gavin A.C. Chung, Joël Lelièvre and Robert H. Bates and has published in prestigious journals such as Science, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Lluís Ballell

64 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lluís Ballell Spain 28 1.1k 953 701 553 212 64 2.1k
Jana Korduláková Slovakia 26 1.4k 1.3× 1.2k 1.3× 716 1.0× 937 1.7× 183 0.9× 55 2.4k
Héctor R. Morbidoni Argentina 20 969 0.9× 1.1k 1.2× 415 0.6× 767 1.4× 203 1.0× 44 2.0k
Anna M. Upton United States 26 1.2k 1.1× 1.2k 1.2× 335 0.5× 693 1.3× 209 1.0× 41 2.0k
Giuseppe Manfroni Italy 30 869 0.8× 626 0.7× 771 1.1× 330 0.6× 325 1.5× 81 2.1k
João Neres United Kingdom 21 946 0.9× 647 0.7× 510 0.7× 394 0.7× 132 0.6× 29 1.5k
Katarı́na Mikus̃ová Slovakia 30 2.0k 1.9× 1.6k 1.6× 1.1k 1.6× 1.1k 2.1× 220 1.0× 57 3.2k
Marco Pieroni Italy 23 771 0.7× 493 0.5× 683 1.0× 332 0.6× 117 0.6× 58 1.6k
Luke J. Alderwick United Kingdom 27 1.3k 1.3× 715 0.8× 398 0.6× 594 1.1× 174 0.8× 54 2.1k
Alessandro De Logu Italy 31 778 0.7× 598 0.6× 949 1.4× 470 0.8× 71 0.3× 62 2.3k
Serena Massari Italy 27 709 0.7× 450 0.5× 645 0.9× 378 0.7× 190 0.9× 75 1.7k

Countries citing papers authored by Lluís Ballell

Since Specialization
Citations

This map shows the geographic impact of Lluís Ballell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lluís Ballell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lluís Ballell more than expected).

Fields of papers citing papers by Lluís Ballell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lluís Ballell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lluís Ballell. The network helps show where Lluís Ballell may publish in the future.

Co-authorship network of co-authors of Lluís Ballell

This figure shows the co-authorship network connecting the top 25 collaborators of Lluís Ballell. A scholar is included among the top collaborators of Lluís Ballell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lluís Ballell. Lluís Ballell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilburn, Kaley M., Christine R. Montague, J.C. Grigg, et al.. (2023). Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in Mycobacterium tuberculosis by the Novel Drug Candidate GSK2556286. Antimicrobial Agents and Chemotherapy. 67(1). e0129422–e0129422. 18 indexed citations
2.
Huang, Wei, Janneth Rodrigues, Etienne Bilgo, et al.. (2023). Delftia tsuruhatensis TC1 symbiont suppresses malaria transmission by anopheline mosquitoes. Science. 381(6657). 533–540. 25 indexed citations
3.
Moure, Abraham L., Gagandeep Narula, Flavia Sorrentino, et al.. (2020). MymA Bioactivated Thioalkylbenzoxazole Prodrug Family Active against Mycobacterium tuberculosis. Journal of Medicinal Chemistry. 63(9). 4732–4748. 9 indexed citations
4.
Trofimov, Valentin, Sébastien Kicka, Nabil Hanna, et al.. (2018). Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets. Scientific Reports. 8(1). 3939–3939. 24 indexed citations
5.
Möllmann, Ute, Kerstin Voigt, Chun‐wa Chung, et al.. (2018). Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1. Scientific Reports. 8(1). 13473–13473. 45 indexed citations
6.
Richard‐Greenblatt, Melissa, Tingting Huang, Shuangjun Lin, et al.. (2018). Synthesis, antimycobacterial activity and influence on mycobacterial InhA and PknB of 12-membered cyclodepsipeptides. Bioorganic & Medicinal Chemistry. 26(12). 3166–3190. 3 indexed citations
7.
Cunningham, Fraser, et al.. (2017). Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent. PLoS ONE. 12(4). e0176088–e0176088. 29 indexed citations
8.
Abrahams, Katherine A., Jonathan A. G. Cox, Klaus Fütterer, et al.. (2017). Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface. Scientific Reports. 7(1). 9430–9430. 46 indexed citations
9.
Rogacki, Maciej K., Sophie Huss, Fraser Cunningham, et al.. (2016). Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides. Journal of Medicinal Chemistry. 59(14). 6709–6728. 42 indexed citations
10.
Pajk, Stane, Roman Šink, Izidor Sosič, et al.. (2016). New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold. European Journal of Medicinal Chemistry. 112. 252–257. 25 indexed citations
11.
Ballell, Lluís, et al.. (2016). Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases. Nature Reviews Drug Discovery. 15(4). 292–292. 10 indexed citations
12.
Kumar, Anuradha, Gonzalo Colmenarejo, Esther Pérez‐Herrán, et al.. (2015). A Focused Screen Identifies Antifolates with Activity on Mycobacterium tuberculosis. ACS Infectious Diseases. 1(12). 604–614. 23 indexed citations
13.
Garcia‐Bennett, Alfonso E. & Lluís Ballell. (2015). Non-absorbable mesoporous silica for the development of protein sequestration therapies. Biochemical and Biophysical Research Communications. 468(3). 428–434. 5 indexed citations
14.
Ordas, Anita, Fraser Cunningham, Hans J. Jansen, et al.. (2014). Testing Tuberculosis Drug Efficacy in a Zebrafish High-Throughput Translational Medicine Screen. Antimicrobial Agents and Chemotherapy. 59(2). 753–762. 51 indexed citations
15.
Poce, Giovanna, Robert H. Bates, Salvatore Alfonso, et al.. (2013). Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection. PLoS ONE. 8(2). e56980–e56980. 77 indexed citations
16.
Kupferschmidt, Natalia, Xin Xia, Roberto H. Labrador, et al.. (2012). In Vivo Oral Toxicological Evaluation of Mesoporous Silica Particles. Nanomedicine. 8(1). 57–64. 16 indexed citations
17.
Hontoria, Francisco, et al.. (2012). A revision of Artemia biodiversity in Macaronesia. PubMed. 8(1). 25–25. 8 indexed citations
18.
19.
Ballell, Lluís, et al.. (2006). A new chemical probe for the detection of the cancer-linked galectin-3. Organic & Biomolecular Chemistry. 4(23). 4387–4387. 47 indexed citations
20.
Ballell, Lluís, Robert A. Field, Gavin A.C. Chung, & Robert J. Young. (2006). New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents. Bioorganic & Medicinal Chemistry Letters. 17(6). 1736–1740. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jana Korduláková Breakdown of academic impact, for papers by Héctor R. Morbidoni Breakdown of academic impact, for papers by Anna M. Upton Breakdown of academic impact, for papers by Giuseppe Manfroni Breakdown of academic impact, for papers by João Neres Breakdown of academic impact, for papers by Katarı́na Mikus̃ová Breakdown of academic impact, for papers by Marco Pieroni Breakdown of academic impact, for papers by Luke J. Alderwick Breakdown of academic impact, for papers by Alessandro De Logu Breakdown of academic impact, for papers by Serena Massari
Rankless by CCL
2026